NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Forecast

$0.397
+0 (+0%)
At Close: Feb 28, 2023
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Applied Genetic Technologies Corporation Stock and on which exchange is it traded?
The symbol for Applied Genetic Technologies Corporation is AGTC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Applied Genetic Technologies Corporation Stock?
Applied Genetic Technologies Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Applied Genetic Technologies Corporation Stock?
Applied Genetic Technologies Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Applied Genetic Technologies Corporation Stock.

What's the current price of Applied Genetic Technologies Corporation Stock?
As of the end of day on the 2023-02-28, the price of an Applied Genetic Technologies Corporation (AGTC) share was $0.397.

What is the 52-week high and low for Applied Genetic Technologies Corporation Stock?
The 52-week high for Applied Genetic Technologies Corporation Stock is $2.03 and the 52-week low is $0.230.
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT